Poster exhibition
Viral vectors and gene therapy

Programme

• • Poster
  • P 404

  Analysis of the prevalence of binding and neutralizing antibodies against 39 human Adenovirus types in student cohorts reveals low-prevalence types and a decline in binding antibody levels during the SARS-CoV-2 pandemic

  • Xiaoyan Wang (Essen / DE)

   Vaccines, Viral vectors and gene therapy
• • Poster
  • P 405

  Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene expression across passages

  • Patrick Neckermann (Regensburg / DE)

   Vaccines, Viral vectors and gene therapy
• • Poster
  • P 406

  Influenza A virus chimeric OP7 defective interfering particles – cell culture-based production and in vivo antiviral efficacy

  • Lars Pelz (Magdeburg / DE)

   Viral vectors and gene therapy
• • Poster
  • P 407

  Generation of an attenuated chimeric bat influenza A virus live-vaccine prototype

  • Sebastian Giese (Freiburg / DE)

   Viral vectors and gene therapy
• • Poster
  • P 408

  Activation of the immune response against HCMV via NKG2D signaling

  • Anna Rebecca Siemes (Hannover / DE)

   Viral vectors and gene therapy
• • Poster
  • P 409

  Impact of deletions in the gene block ORF11-13 in the varicella-zoster virus vaccine strain Oka genome on glycoprotein gE and gI expression in permissive cells

  • Elena Hildebrand (Kiel / DE)

   Viral vectors and gene therapy
• • Poster
  • P 410

  Varicella zoster virus vaccine strain Oka variants withreduced genome size, reduced pathogenic potential andtheir replication properties in permissive melanoma cells and fibroblasts

  • Julius Völkl (Kiel / DE)

   Viral vectors and gene therapy
• • Poster
  • P 411

  Novel adenovirus vectors for efficient transduction of human hematopoietic stem cells and peripheral blood monocyte subsets

  • Dr. Wenli Zhang (Witten / DE)

   Viral vectors and gene therapy, Virus receptors and entry
• • Poster
  • P 412

  Generation of proof-of-principle barcoded recombinant Adenovirus libraries allowing for novel medical and laboratory applications

  • Julian Fischer (Freiburg / DE)

   Vaccines, Viral vectors and gene therapy
• • Poster
  • P 413

  Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA facilitate high vector yields and production in bioreactors

  • Yasemin van Heuvel (Leverkusen / DE)

   Viral vectors and gene therapy
• • Poster
  • P 414

  CRISPR Cas13 as an antiviral tool against respiratory RNA viruses

  • Anna Carolina Kuge (Hannover / DE)

   Viral vectors and gene therapy
• • Poster
  • P 415

  Development of improved peptide nanofibrils as transduction enhancers for CAR-T cell therapy

  • Lena Rauch-Wirth (Ulm / DE)

   Viral transformation and oncogenesis, Viral vectors and gene therapy